{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:56:19Z","timestamp":1778270179161,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.carrev.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T03:18:59Z","timestamp":1519960739000},"page":"852-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PB","title":["Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"19","author":[{"given":"Leonidas","family":"Palaiodimos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damianos G.","family":"Kokkinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Faillace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Raymond","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mastoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.carrev.2018.02.014_bb0005","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carrev.2018.02.014_bb0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.carrev.2018.02.014_bb0015","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.carrev.2018.02.014_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaneurol.2013.575","article-title":"Ischemic stroke and transient ischemic attack in young adults: Risk factors, diagnostic yield, neuroimaging, and thrombolysis","volume":"70","author":"Ji","year":"2013","journal-title":"JAMA Neurol"},{"issue":"3\u20134","key":"10.1016\/j.carrev.2018.02.014_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000434760","article-title":"Phenotypic ASCO characterisation of young patients with ischemic stroke in the prospective multicentre observational SIFAP1 study","volume":"40","author":"Wolf","year":"2015","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.carrev.2018.02.014_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.04.063","article-title":"Paradoxical embolism","volume":"64","author":"Windecker","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2018.02.014_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11883-007-0039-y","article-title":"Cryptogenic stroke in patients with patent foramen ovale","volume":"9","author":"Saver","year":"2007","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"10.1016\/j.carrev.2018.02.014_bb0040","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","article-title":"Patent foramen ovale in cryptogenic stroke","volume":"40","author":"Alsheikh-Ali","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2018.02.014_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2010","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.carrev.2018.02.014_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.carrev.2018.02.014_bb0055","first-page":"343","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"d5928","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2018.02.014_bb0060","first-page":"342","article-title":"Interpretation of random effects meta-analyses","volume":"d549","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"10.1016\/j.carrev.2018.02.014_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.carrev.2018.02.014_bb0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0080","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.carrev.2018.02.014_bb0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0095","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.carrev.2018.02.014_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.02.014_bb0110","article-title":"Patent foramen ovale closure and medical treatments for secondary stroke prevention","author":"Kitsios","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.carrev.2018.02.014_bb0115","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.57.7.1330","article-title":"Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism","volume":"57","author":"Wahl","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.carrev.2018.02.014_bb0120","series-title":"Transcatheter Closure of Patent Foramen Ovale, An Issue of Interventional Cardiology Clinics","author":"Price","year":"2017"},{"issue":"6","key":"10.1016\/j.carrev.2018.02.014_bb0125","first-page":"889","article-title":"New onset atrial fibrillation after patent foramen ovale closure","volume":"74","author":"Staubach","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2018.02.014_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","article-title":"Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis","volume":"100","author":"Wolfrum","year":"2014","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.carrev.2018.02.014_bb0135","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.carrev.2018.02.014_bb0140","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2018.02.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score\u2013based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. The IPSYS Registry (Italian Project on Stroke in Young Adults)","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2018.02.014_bb0150","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","article-title":"Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)","volume":"101","author":"Taaffe","year":"2008","journal-title":"Am J Cardiol"},{"issue":"43","key":"10.1016\/j.carrev.2018.02.014_bb0155","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","article-title":"Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale","volume":"34","author":"Hornung","year":"2013","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.carrev.2018.02.014_bb0160","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"J Am Coll Cardiol Intv"},{"issue":"3","key":"10.1016\/j.carrev.2018.02.014_bb0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.15420\/aer.2014.3.3.168","article-title":"Pathophysiology and management of arrhythmias associated with atrial septal defect and patent foramen ovale","volume":"3","author":"Chubb","year":"2014","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"1","key":"10.1016\/j.carrev.2018.02.014_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0317167100004674","article-title":"Stroke recurrence and its prevention in patients with patent foramen ovale","volume":"33","author":"Harrer","year":"2006","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"10.1016\/j.carrev.2018.02.014_bb0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10072-006-0524-z","article-title":"Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study","volume":"26","author":"Cerrato","year":"2006","journal-title":"Neurol Sci"},{"issue":"8","key":"10.1016\/j.carrev.2018.02.014_bb0180","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1747-4949.2012.00843.x","article-title":"The Risk of Paradoxical Embolism (RoPE) Study: Initial description of the completed database","volume":"8","author":"Thaler","year":"2013","journal-title":"Int J Stroke"},{"issue":"7","key":"10.1016\/j.carrev.2018.02.014_bb0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.carrev.2018.02.014_bb0190","first-page":"A73-A","article-title":"Abstract 73: Risk of Paradoxical Embolism (RoPE) score stratification of pooled Pfo closure clinical trial data: lack of evidence for improvement in patient selection for closure","volume":"48","author":"Thaler","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.carrev.2018.02.014_bb0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.amjcard.2017.11.037","article-title":"Meta-analysis comparing patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke","volume":"121","author":"Ando","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2018.02.014_bb0200","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.jcin.2017.09.002","article-title":"Transcatheter patent foramen ovale closure after cryptogenic stroke an updated meta-analysis of randomized trials","volume":"10","author":"Mojadidi","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2018.02.014_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.carrev.2018.02.014_bb0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/M17-3033","article-title":"Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis","volume":"168","author":"De Rosa","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.carrev.2018.02.014_bb0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M17-2679","article-title":"Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis","volume":"168","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.carrev.2018.02.014_bb0220","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/01.STR.0000135773.24116.18","article-title":"Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale","volume":"35","author":"Homma","year":"2004","journal-title":"Stroke"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918300861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918300861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:49Z","timestamp":1761560029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918300861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1553838918300861"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.02.014","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}